https://tiakis.bio/partnering 2023-05-16T10:02:33+02:00 0.5 https://tiakis.bio 2024-12-08T10:56:28+01:00 1 https://tiakis.bio/why-tiprelestat 2024-12-08T11:05:51+01:00 0.5 https://tiakis.bio/about 2024-12-08T11:07:09+01:00 0.5 https://tiakis.bio/career 2023-04-04T13:49:59+02:00 0.5 https://tiakis.bio/news 2022-09-27T11:47:02+02:00 0.5 https://tiakis.bio/news/first-patient-dosed-in-phase-ib-ii-trial-evaluating-tiprelestat-for-treatment-of-covid-19 2023-06-13T09:29:39+02:00 0.3 https://tiakis.bio/news/successful-tech-transfer-and-expansion-of-manufacturing-capabilities-for-tiprelestat 2023-05-16T09:42:09+02:00 0.3 https://tiakis.bio/news/tiakis-elafin-enters-the-clinic-for-subcutaneous-use-in-pulmonary-arterial-hypertension 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/tiakis-receives-glp-certificate-from-competent-authority 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/new-mechanism-of-elafin-to-prevent-lung-injury-in-mechanically-ventilated-newborns 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/proteo-biotech-ag-becomes-tiakis-biotech-ag 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/tiakis-biotech-ag-has-partnered-with-northway-biotech-to-scale-up-its-production-capabilities 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/german-federal-ministry-of-education-and-research-selects-tiakis-biotech-ag-to-develop-tiprelestat-as-a-potential-therapeutic-fo 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/new-anchor-investor-elevat3-capital-joins-tiakis-biotech-ag 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/move-to-a-new-and-larger-office-in-kiel-germany 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/clinical-trial-phase-1-completed 2023-05-16T09:31:17+02:00 0.3 https://tiakis.bio/news/tiakis-biotech-ag-reports-clinical-phase-ib-ii-trial-results-of-tiprelestat-for-the-treatment-of-hospitalized-covid-19-patients 2024-12-08T11:18:29+01:00 0.3 https://tiakis.bio/news/tiakis-biotech-ag-receives-positive-scientific-advice-from-the-u-s-fda-for-planned-phase-ii-trial-of-tiprelestat 2025-01-08T09:51:22+01:00 0.3 https://tiakis.bio/news/tiakis-biotech-ag-participates-in-kol-webcast-on-pulmonary-arteri 2025-04-02T08:22:42+02:00 0.3 https://tiakis.bio/news/tiakis-biotech-ag-announces-appointment-of-ex-actelion-executive-christoph-schmidt-as-new-supervisory-board-member 2025-05-22T09:33:05+02:00 0.3 https://tiakis.bio/news/stanford-university-secures-nih-grant-to-advance-tiakis-biotech-s-elafin-tiprelestat-through-a-u-s-phase-ii-trial-in-pulmonary-a 2025-09-08T08:50:40+02:00 0.3 https://tiakis.bio/news/tiakis-biotech-successfully-completes-data-package-to-advance-tiprelestat-into-phase-ii-clinical-trial-in-pah 2025-12-02T09:09:30+01:00 0.3 https://tiakis.bio/imprint 2024-05-07T10:47:18+02:00 0.5 https://tiakis.bio/data-protection 2025-12-02T09:19:58+01:00 0.5